Skip to main content
Liana Apostolova, MD, Neurology, Indianapolis, IN

LianaGApostolovaMD

Neurology Indianapolis, IN

Indiana University Distinguished Professor, Barbara and Peer Baekgaard Professor in Alzhiemer's Disease Research - Indiana University School of Medicine; Professor of Neurology, Radiology, Medical and Molecular Genetics - Indiana University; Director of the UCLA-Easton Neuroimaging Laboratory - UCLA

Dr. Apostolova is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Apostolova's full profile

Already have an account?

  • Office

    355 W 16th St
    Ste 3200
    Indianapolis, IN 46202
    Phone+1 317-948-5450
    Fax+1 317-963-7533

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Neurology, 2000 - 2003
  • Advocate Health Care/Advocate Illinois Masonic Medical Center
    Advocate Health Care/Advocate Illinois Masonic Medical CenterInternship, Internal Medicine, 1999 - 2000
  • Medical University of Sofia FOM
    Medical University of Sofia FOMClass of 1998

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2015 - 2025
  • CA State Medical License
    CA State Medical License 2003 - 2019
  • IA State Medical License
    IA State Medical License 2000 - 2004
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • IU School of Medicine Names Apostolova Associate Dean for Alzheimer’s Disease Research
    IU School of Medicine Names Apostolova Associate Dean for Alzheimer’s Disease ResearchMay 11th, 2023
  • FDA Advisors Vote Against Effectiveness of Biogen’s ALS Drug for Rare and Aggressive Form of the Disease
    FDA Advisors Vote Against Effectiveness of Biogen’s ALS Drug for Rare and Aggressive Form of the DiseaseMarch 22nd, 2023
  • FDA Advisors Reject Accelerated Approval of Biogen’s ALS Drug
    FDA Advisors Reject Accelerated Approval of Biogen’s ALS DrugMarch 22nd, 2023
  • Join now to see all